New blood processing method could mean fewer transfusions for sickle cell patients
Disease control
Not yet recruiting
This study tests whether red blood cells processed with the Hemanext ONE® system (hypoxic RBCs) last longer in the body compared to standard blood transfusions for people with sickle cell anemia. About 48 participants aged 7 and older who need regular transfusions will receive bo…
Phase: NA • Sponsor: Hemanext • Aim: Disease control
Last updated May 07, 2026 18:39 UTC